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Background: Cardiac sarcoidosis is a life-threatening disease with protean clinical
manifestations, including congestive heart failure (CHF), conduction disturbance,
ventricular arrhythmia and sudden death. Nonetheless, it is difficult to diagnose
cardiac sarcoidosis in the clinical setting. Some echocardiographic findings of cardiac
sarcoidosis associated with other diagnostic tools (201thallium scintigraphy, 67gallium
citrate scan, serum markers and others) may be helpful upon early suspicion and
diagnosis of cardiac sarcoidosis.
Materials and Methods: Fifty-two patients (36 female) with cardiac sarcoidosis,
with a mean age of 48 ± 14 years (range, 21–70 yr), underwent a series of
echocardiographic follow-up (mean, 88 ± 48 mo) examinations, and important
echocardiographic parameters and findings were recorded.
Results: There were left ventricular (LV) regional wall motion abnormalities
(RWMAs) noted in 40 (localized in 16, multiple in 24), dilatation of the LV with
impaired LV contractility in 28, thinning of the basal interventricular septum (IVS)
in 27, thinning of LV free wall in 18, apical aneurysm in 12, apical thrombus in
two, mimicking hypertrophic cardiomyopathy (HCM) in two, pericardial effusion
(PE) in two (with cardiac tamponade in one), and LV wall thinning and aneurysm
formation after steroid therapy for cardiac sarcoidosis in two of 43 patients.
Conclusion: Thinning of the basal IVS or LV free wall is a specific
echocardiographic finding of cardiac sarcoidosis. Other echocardiographic findings
of cardiac sarcoidosis may mimic coronary artery disease (LV RWMA or apical
aneurysm), CHF, or HCM. PE and thinning of the LV wall after steroid therapy
were also noted in rare situations.
(J Med Ultrasound 2002;10:135–140)
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INTRODUCTION
Sarcoidosis is a systemic granulomatous disease of
unknown etiology involving multiple organs, includ-
ing lungs, lymph nodes, eyes, skin, heart, liver and
others [1–3]. Cardiac involvement is documented in
20%–30% of patients with sarcoidosis on autopsy,
but clinical cardiac manifestations are seen in only
about 5% of patients. Cardiac sarcoidosis is defini-
tively diagnosed histologically on finding typical
noncaseating epithelioid granuloma cells, but the
positive rate of endomyocardial biopsy is low (around
20%–30%) [4–8]. Cardiac sarcoidosis may lead to
serious clinical events, such as ventricular arrhythmia,
sudden cardiac death, conduction disturbance and
refractory congestive heart failure (CHF). Morbidity
and mortality due to CHF or ventricular arrhythmia
are also high [9, 10]. Echocardiography in patients
with cardiac sarcoidosis may have specific or non-
specific findings. The purpose of this study was to
assess the incidence of abnormal echocardiographic
findings of cardiac sarcoidosis in a single center and to
determine the specific and nonspecific findings helpful
for early suspicion or diagnosis of cardiac sarcoidosis.
MATERIALS AND METHODS
Subjects
The records of patients who were diagnosed with
cardiac sarcoidosis between January 1990 and June
2001 were analyzed retrospectively. We diagnosed
patients with cardiac sarcoidosis according to the
criteria proposed by the Specific Diffuse Pulmonary
Disease Research Group, Sarcoidosis Division [11].
The diagnostic criteria were grouped histologically
and clinically. (1) Histologic diagnostic group:
endomyocardial biopsy or surgery revealed
noncaseating necrosis with epithelioid granuloma
cells in the myocardium. (2) Clinical diagnostic
group: an organ other than the heart was histologically
positive for sarcoidosis criterion A and at least one
criterion from B to E. These criteria include: A)
Electrocardiography (ECG) or 24-hour holter moni-
toring revealed right bundle branch block, left axis
deviation, atrioventricular block, ventricular
tachycardia, ventricular premature contractions
(VPCs), ≥ Lown grade 2, abnormal Q wave or ST-
T change. B) Echocardiography revealed left ven-
tricular (LV) regional wall motion abnormality
(RWMA), localized wall thinning or hypertrophy,
or LV chamber dilatation. C) 201thallium, 67gallium
citrate or 99mtechnetium-PYP scintigraphy abnormality.
D) Cardiac catheterization revealed abnormal
intracardiac pressure or low cardiac output. Left
ventriculography revealed RWMA or low ejection
fraction (EF). E) Endomyocardial biopsy revealed
nonspecific change and at least moderate grade
interstitial fibrosis or cellular infiltration. (3) Clini-
cally highly suspected group: Patients did not have
a definitive histologic diagnosis but met criteria A
to E, leading to a strong suspicion of cardiac sarcoidosis.
There were 52 patients (16 men and 36 women),
and their average age was 48 ± 14 years (range,
21–71). Of the 52 patients studied, 36 (69%) had
positive histologic findings (noncaseating epithelioid
granulomas) in the heart, lymph nodes, lung or skin.
Sixteen patients (31%) showed positive right ven-
tricular endomyocardial biopsy. Pulmonary involve-
ment was noted in 12 (23%), skin lesions in 10
(19%) and eye involvement in 14 (27%) patients.
Among these patients, echocardiography, ECG,
myocardial perfusion scintigraphy, gallium scan,
radionuclide ventriculography, cardiac catheteriza-
tion with right ventricular biopsy, serum angiotensin
converting enzyme and lysozyme levels, clinical
cardiac events (chest pain, conduction disturbance,
lethal arrhythmia, CHF and sudden cardiac death)
and mortality were investigated during the follow-
up period.
Ultrasound examination
All patients underwent a series of echocardiographic
examinations during follow-up (mean, 88 ± 48 mo;
range, 1–196) with commercially available ultra-
sound systems (SSD 870, Aloka, Tokyo, Japan;
SSH-160A, Toshiba, Tokyo, Japan; or Sonos 2000,
Sonos  5500,  Hewlet t -Packard ,  Andover ,
Massachusetts) and a 2.5-MHz imaging transducer.
Thickness of IVS and LV posterior wall, LV end-
diastolic diameter and LV end-systolic diameter
were determined using M-mode echocardiography.
LV end-diastolic and end-systolic volumes, and EF
were also measured. Typical echocardiographic find-
ings of cardiac sarcoidosis, including LV RWMA,
thinning or hypertrophy of LV wall, thinning of the
base of IVS and LV aneurysm were also recorded.
Definitions
The LV was divided into 16 segments and RWMA
in each segment was evaluated (hypokinesia, akinesia,
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dyskinesia). LV diastolic dysfunction was defined
as reduced height of the E wave and increased height
of the A wave, with an E/A ratio of less than one,
accompanied by prolongations of the isovolumic
relaxation time (IVRT) and deceleration time (DT).
Pulmonary hypertension was defined as shortening
of the pulmonary acceleration time (ACT), decrease
of the ratio between the pulmonary ACT and pul-
monary ejection period or tricuspid regurgitation
(TR) pressure gradient measured by continuous wave
Doppler plus 10 mmHg (right atrium pressure) more
than 30 mmHg. Severity of mitral regurgitation
(MR) and TR were measured using semiquantitative
flow mapping scored as 1+ (mild regurgitation), 2
to 3+ (moderate regurgitation) or 4+ (severe
regurgitation). Severe MR was associated with
systolic reversal of pulmonary vein flow. Severe TR
was associated with systolic reversal flow of hepatic
vein flow). Hypertrophic cardiomyopathy (HCM)
was defined as localized or generalized thickening
of the IVS or LV free wall with (obstructive) or
without dynamic obstruction of the LV outflow tract
(LVOT). Cardiac tamponade was defined as diastolic
collapse of the right ventricle (and right atrium). The
Lown classification of VPC was as follows: grade 0
(no VPC), grade 1 (single or sporadic VPC), grade
2 (frequent, > 30 VPCs per min), grade 3 (multifocal
VPCs), grade 4 (repetitive, two couplets or more
than three continuous VPCs), grade 5 (VPCs with
R on T phenomenon).
RESULTS
Among the 52 patients undergoing echocardiographic
examinations, LV RWMA were noted among 40
patients (Figs. 1 and 2). Sixteen patients had single
localized and the other 24 had multiple RWMA.
Dilatation of the LV with impaired LV contractility
was also noted in 28 patients (Fig. 1). Among all
52 patients, echocardiographic findings of basal IVS
thinning typical of cardiac sarcoidosis was noted in
27 (Fig. 2) and LV free wall thinning was noted
in 18 patients (Fig. 3). LV apical aneurysm with
dyskinesia was detected in 12 patients and two of
them had apical thrombi (Fig. 4). Cardiac sarcoido-
sis mimicking HCM was noted in two (Fig. 5),
pericardial effusion (PE) in two (with cardiac tam-
ponade in one), and LV wall thinning and aneurysm
formation in two of 43 patients after steroid therapy
Fig. 1. Parasternal short axis view in a 70-year-old
woman with cardiac sarcoidosis. Left: diastolic phase.
Right: systolic phase; poor left ventricular ejection fraction
(25% by M mode calculation and 16% by modified
Simpson’s method) with inferoposterior wall akinesia and
anteroseptal wall hypokinesia. Thallium scintigraphy also
revealed multiple perfusion defects. Coronary angiography
showed patent coronary arteries.
Fig. 2. Parasternal long axis view in a 40-year-old woman
with cardiac sarcoidosis. The figure shows typical thinning
of the base of the interventricular septum.
for cardiac sarcoidosis. LV diastolic dysfunction
with early filling/atrial contraction (E/A) flow re-
versal was noted in 27 patients. Mitral regurgitation
was noted in 33 patients (1+ in 18, 2 to 3+ in nine,
and 4+ in six). Tricuspid regurgitation was noted in
26 patients (1+ in 11, 2 to 3+ in eight and 4+ in
seven) and pulmonary hypertension detected by
echocardiography was noted in 15 patients. The
echographic findings are shown in the Table.
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DISCUSSION
Cardiac sarcoidosis is a serious disease with severe
morbidity and high mortality. Its clinical diagnosis
is a challenging task. Cardiac sarcoidosis should be
suspected in patients with clinical symptoms or signs
of sarcoidosis along with abnormal echocardiographic
or scintigraphic findings [12–16]. In patients with
sarcoidosis, cardiac involvement is noted in 20% to
50% of patients. Moiseyev reported echocardiographic
abnormalities in 33 of 90 patients with systemic
sarcoidosis [17]. There were LV dilatation and im-
paired LV contractility in 21, LV wall thickening
Fig. 3. Parasternal short axis view in a 65-year-old
woman with cardiac sarcoidosis. The figure shows thinning
of the base of the interventricular septum.
Fig. 4. Apical four chamber view in a 45-year-old woman
with cardiac sarcoidosis. The figure reveals apical
dyskinesia of left ventricle with thrombus formation.
Electrocardiography showed QS patterns in the precordial
lead. Nonetheless, coronary angiography showed patent
coronary arteries.
Fig. 5. Parasternal short axis view in a 68-year-old
woman with cardiac sarcoidosis. The figure reveals
localized hypertrophy of anterior wall (thickness =
17 mm). No pressure gradient was noted in left ventricular
outflow tract.
in eight, LV wall thinning in seven and PE in five
patients, according to his report. Burstow reported
LV RWMA in 12 of 88 patients with systemic
sarcoidosis [18]. Of these 12 patients, nine had a
history of CHF. Valantine also emphasized that cardiac
sarcoidosis should be highly suspected in patients with
basal IVS thinning [19]. Echocardiography in our
patients also had the same specific and nonspecific
findings, suggesting cardiac involvement of
sarcoidosis.
Thinning of the basal IVS or LV free wall is
a typical and specific finding of cardiac sarcoidosis,
and may be helpful for establishing early suspicion
and diagnosis of cardiac sarcoidosis. It was a com-
mon finding and was noted in more than one-half
of our patients on echocardiography. Nonspecific
echocardiographic findings of cardiac sarcoidosis
may mimic coronary artery disease (CAD), CHF or
HCM. LV RWMA is the most common nonspecific
finding of cardiac sarcoidosis detected by
echocardiography. In our patients, most of them
were young and did not have any risk factors for
CAD. In addition, we found sarcoidosis in other
organs in association with abnormal scintigraphic
findings, abnormal serum markers for cardiac sar-
coidosis (ACE or lysozyme) and patent coronary
arteries on coronary angiography. Thus, we could
rule out the possibility of CAD and thought it was
granulomatous involvement in a single or multiple
regions of the LV.
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LV chamber dilatation with impaired LV func-
tion was the second most common echocardiographic
manifestation of patients with cardiac sarcoidosis.
Symptoms or signs of CHF were also noted in most
of these patients. LV apical aneurysm with or without
an apical thrombus mimicking anterior wall myo-
cardial infarction (MI) also occurred in some patients.
ECG of these patients can reveal ST elevation and
QS patterns in the precordial leads, with
echocardiography also showing LV dyskinesia.
Nonetheless, the coronary arteries of these patients
were all patent. Kosuge et al also reported a case
of cardiac sarcoidosis with apical aneurysm [20, 21].
They thought that myocardial necrosis due to granu-
lomatous inflammation was the main cause of apical
aneurysm formation. In rare situations, cardiac sar-
coidosis may present as an HCM-like manifestation
on echocardiographic studies. We found localized
or generalized thickening of three IVS or other
portions of the LV, with or without a dynamic
pressure gradient in the LVOT. Matsumori et al
reported six cases of cardiac sarcoidosis mimicking
HCM [22]. The manifestations of hypertrophy in-
cluded IVS hypertrophy in four, asymmetrical septal
hypertrophy in two, localized hypertrophy in one
and apical hypertrophy in one. Yazaki et al thought
that sarcoidosis mimicking HCM could be differ-
entiated from true HCM by radionuclide image
studies [23]. Because in cases of cardiac sarcoidosis
mimicking HCM, thallium or gallium scan revealed
perfusion defects or abnormal uptake in the hyper-
trophic myocardium.
LV diastolic dysfunction also occurred in over
one-half of patients with cardiac sarcoidosis. It may
have been due to impaired LV function, LV chamber
dilatation, increased LV filling pressure or poor LV
compliance. MR may be due to LV chamber
dilatation, mitral annulus dilatation or papillary muscle
involvement of cardiac sarcoidosis. TR and pulmo-
nary hypertension may result from left heart failure
or primary pulmonary sarcoidosis. In two of 43
patients undergoing steroid therapy for cardiac
sarcoidosis, apical wall thinning and aneurysm for-
mation were noted. The cause of aneurysm forma-
tion may be the result of steroid therapy or the
natural course of cardiac sarcoidosis [21–23].
In conclusion, cardiac sarcoidosis may have
various echocardiographic findings. IVS base and
LV free wall thinning are typical and specific find-
ings helpful for early suspicion and diagnosis of
cardiac sarcoidosis. Other nonspecific findings may
mimic CAD, CHF or HCM, and therefore, other
diagnostic tools are needed to help establish the
final clinical diagnosis. In rare situations, PE (with
or without cardiac tamponade) is another
echocardiographic finding.
Table. Echocardiographic findings in patients with cardiac sarcoidosis
Echocardiographic finding n (%)
Specific
Thinning of basal IVS 27 (52)
Thinning of LV free wall 18 (35)
Nonspecific
Impaired LVEF/chamber dilatation 28 (54)
LV RWMA 40 (77)
Apical aneurysm 12 (23)
Apical thrombus 2 (4)
Hypertrophic cardiomyopathy 2 (4)
Pericardial effusion 2 (4)
Cardiac tamponade 1 (2)
Mitral regurgitation 33 (63)
Tricuspid regurgitation 26 (50)
LV diastolic dysfunction 27 (52)
IVS = interventricular septum; LV = left ventricular; LVEF = left ventricular ejection fraction; RWMA = regional wall
motion abnormality.
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